Enabling drug release from medical devices.

PolyActiva Pty Ltd uses a unique drug-polymer conjugate technology to enable site specific drug delivery from medical device components, such as implants, films or fibres.

The drug-polymer conjugate technology has the following key features:

  • High Dose Loadings
  • Sustained Drug Release
  • Complete Bioerosion
  • Drug Released in Active Form
  • Device Forming Capability
  • Non-Toxic By-Products from Polymer Erosion


PolyActiva has developed a unique platform drug-polymer conjugate technology.


Our existing product portfolio focuses on development of the following products: